Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Appointment

30 Jan 2008 07:01

ViaLogy PLC30 January 2008 VIALOGY PLC APPOINTS HEAD OF OPERATIONS AND ENGINEERING London, January 30, 2008 - ViaLogy PLC (AIM: VIY), a leading innovator ofnetwork-centric real time signal processing platforms for integrated security,safety, operations management and business continuity applications, todayannounces the appointment of Hugo Fruehauf as Chief Operating Officer (COO) andVice President of Engineering at its wholly-owned American subsidiary company,ViaLogy LLC ('ViaLogy'), of Pasadena, California. This senior appointment strengthens the company's engineering and productioncapabilities and advances efforts to establish its unique product offerings -Sensor Policy Manager (SPM), MicroSPM and MPEX Electronic Eye - in high demandcommercial markets. Fruehauf joins ViaLogy from Frequency Electronics Inc. (FEI), a leadingmanufacturer of precision frequency sources and frequency/time systems forsatellites, missiles, aircraft and a host of ground platforms, where he was VicePresident and Chief Technology Officer (CTO). Hugo has also held President/CEOand CTO positions at subsidiaries of FEI, the Defense Group of AlliantTechsystems, Datum Inc., and Ball-Efratom (a Ball Aerospace company); companiesserving both commercial and military/governmental system markets. Prior tothese roles, while at Rockwell International, he was the Chief Engineer for thedesign and development of the satellite for the now famous GPS GlobalPositioning System. He also played a leading role in the Apollo moon landingprogram, as Chief Test Conductor and Complex Operations Manager for the secondstage of the Saturn V launch vehicle. Mr. Fruehauf is considered a leading expert in GPS navigation, positioning andprecision timing for commercial and military applications, as well as precisionfrequency sources and network cryptographic security technologies. He is also anAdjunct Professor at Pepperdine University. Commenting on his appointment Hugo Fruehauf said: "I'm looking forward to leading an incredibly competent team at the Pasadenafacility and hopefully contribute to innovation, a systems engineering focus,and the operational glue that will bring ViaLogy to its full potential." Welcoming Hugo to ViaLogy, Dr. Robert W. Dean, President/CEO, said: "We are delighted that Hugo is joining the team at ViaLogy. He brings a wealthof experience in product design and development that will be vital as weroll-out our products to the market. We are all looking forward to an excitingyear ahead." Mr. Fruehauf is a Registered Professional Engineer in Control Systems (State ofCalifornia); an Executive MBA graduate (Pepperdine University); an ElectronicEngineering Technology graduate (DeVry University); the compiler of a "PrecisionTime and Frequency Handbook" and a religious book "God Without Dogma"; author ofmany technical papers on atomic oscillators, telecommunications, networkcryptography, and GPS technologies; holds numerous patents; and received awardsfor his role in the Apollo program, GPS, and an IEEE technical paper. ViaLogyRobert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0) 20-7107-8000 PR Consultants - Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0) 20-7822-0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defense and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.